Pathogenetic treatment of diabetic polyneuropathy

dc.contributor.author	Pavlovych, L.B.
dc.contributor.author	Bilous, I.I.
dc.date.accessioned	2018-03-13T08:18:03Z
dc.date.available	2018-03-13T08:18:03Z
dc.date.issued	2017
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13533
dc.description.abstract	The authors have studied the effect of mildronat and thiotriazolin on the processes of lipid peroxidation, the oxidative modification of proteins and the state of the blood antioxidant system 3 and 6 months following a course of multimodality treatment in patients with diabetes mellitus and diabetic polyneuropathy.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Deutscher wissenschaftsherold German science herald. – 2017. – № 3. – Р.20-22.	ru_RU
dc.subject	diabetic polyneuropathy	ru_RU
dc.subject	diabetes	ru_RU
dc.subject	диабетическая полинейропатия	ru_RU
dc.subject	диабет	ru_RU
dc.subject	діабетична полінейропатія	ru_RU
dc.subject	діабет	ru_RU
dc.title	Pathogenetic treatment of diabetic polyneuropathy	ru_RU
dc.type	Article	ru_RU